SilviaC.FormentiMDFASTRO

Clinical Trials

• Chemotherapy and Radiation Therapy With or Without Panitumumab in Treating Patients With Stage IIIA Non-Small Cell Lung Cancer Start of enrollment: 2011 Feb 01

  Completed

  Phase 2

• Study Comparing Whole Breast Radiotherapy With a Daily Versus a Weekly Tumor Start of enrollment: 2009 Mar 01

  Completed

  Phase 3

• Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery Start of enrollment: 2010 Apr 05

  Active, not recruiting

  Phase 3

• Radiation Therapy in Treating Patients With Extensive Stage Small Cell Lung Cancer Start of enrollment: 2010 Mar 01

  Completed

  Phase 2

• Concurrent Adjuvant Carboplatin and Accelerated Radiotherapy for Triple Negative Breast Cancer Start of enrollment: 2009 Mar 06

  Completed

  Phase 1, Phase 2

• Prospective Trial of Two Prone Breast Radiotherapy Techniques With Randomization to Concurrent Versus Weekly Boost Start of enrollment: 2012 Apr 16

  Completed

  Phase 3

• Hypo-Fractionated Radiation Therapy for Localized Prostate Cancer Start of enrollment: 2012 May 01

  Terminated

  Phase 1

• Phase II Randomized Trial of Ipilimumab Versus Ipilimumab and Radiotherapy in Metastatic Melanoma Start of enrollment: 2013 Jan 01

  Terminated

  Phase 2

• Study of Combined Ionizing Radiation and Ipilimumab in Metastatic Non-small Cell Lung Cancer (NSCLC) Start of enrollment: 2014 Jul 01

  Completed

  Phase 1, Phase 2

• LY2157299 Monohydrate (LY2157299) and Radiotherapy in Metastatic Breast Cancer Start of enrollment: 2015 Aug 10

  Terminated

  Phase 2

• Trial to Compare Radiation Fibrosis With Five Versus Three Fractions Start of enrollment: 2015 Jul 01

  Active, not recruiting

  Phase 2

• Randomized Trial of Image -Guided Stereotactic Radiation Therapy (IG-SRT) in Prostate Cancer Start of enrollment: 2016 Sep 01

  Terminated

  Not Applicable

• Radiation and Immune Checkpoints Blockade in Metastatic NSCLC (BMS # CA209-632) Start of enrollment: 2017 Oct 09

  Terminated

  Phase 1, Phase 2

• Effect of Radiotherapy Variables on Circulating Effectors of Immune Response and Local Microbiome Start of enrollment: 2018 Jan 22

  Completed

• Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients Start of enrollment: 2018 Nov 15

  Recruiting

  Phase 1, Phase 2

• Converting HR+ Breast Cancer Into an Individualized Vaccine Start of enrollment: 2020 Mar 17

  Recruiting

  Phase 2

• Prospective Randomized Study of Accelerated Radiation Therapy (PRART) Start of enrollment: 2019 Nov 21

  Recruiting

  Phase 3

• CIMER: Combined Immunotherapies in Metastatic ER+ Breast Cancer Start of enrollment: 2020 Mar 04

  Withdrawn

  Phase 2

• Combined Immunotherapies in Metastatic ER+ Breast Cancer Start of enrollment: 2020 Nov 12

  Recruiting

  Phase 2

• De-convoluting Interactions Between Genes, the Cancer Environment, and the Immune System to Develop Therapies That Work for You Start of enrollment: 2022 Jan 12

  Recruiting

  Roles: Principal Investigator

• Accelerated Radiation Therapy (ART) to the Breast and Nodal Stations Start of enrollment: 2016 Dec 19

  Active, not recruiting

  Phase 1, Phase 2

  Roles: Principal Investigator

• Join now to see all